Literature DB >> 10449077

Use of an acellular dermal allograft for dural replacement: an experimental study.

J M Chaplin1, P D Costantino, M E Wolpoe, J B Bederson, E S Griffey, W X Zhang.   

Abstract

OBJECTIVE: In this study, a nonimmunogenic, acellular, dermal collagen matrix termed XenoDerm (LifeCell Corp., The Woodlands, TX) was examined for use as a dural replacement material in a porcine model. This model was used to investigate whether AlloDerm (LifeCell), an almost identical material made from human dermis, could be safely used in neurological surgery.
METHODS: Bilateral temporoparietal dural defects were surgically created in 12 Yucatan minipigs. One side was repaired with autologous pericranium, and the other was repaired with XenoDerm. The pigs were killed after 1, 3, or 6 months, and the areas of dural repair were collected and examined macroscopically and histologically. XenoDerm is derived from porcine skin collected in thin sheets. It is processed so that the epidermis and all dermal cells are removed without disruption of the collagen matrix, rendering the material immunogenically inert and resistant to calcification. It is packaged as a freeze-dried sheet and is easily rehydrated at the time of surgery.
RESULTS: There were no postoperative complications, and all pigs survived. Both grafts performed well as dural replacements in all cases. There was no macroscopic evidence of inflammation or cerebrospinal fluid leakage. The XenoDerm grafts were intact, retained their original dimensions, and resembled the surrounding dura. The autologous pericranial grafts, in contrast, were thicker than when implanted and had bony excrescences firmly adhering to their surfaces. Again, however, there was no evidence of cerebrospinal fluid fistulae. There was no gross adherence to the underlying meninges or brain tissue in any specimen. Repopulation by fibroblasts and neovascularization were evident in the XenoDerm grafts as early as 1 month after surgery; by 3 months, the XenoDerm had been remodeled to assume the connective tissue appearance of the surrounding dura.
CONCLUSION: In this porcine model, an allograft of acellular dermis is a nearly ideal dural replacement. AlloDerm, the human equivalent of XenoDerm, would be an allograft of acellular dermis after implantation in human subjects. On the basis of this study and previous work with AlloDerm in other reconstructive applications, it is proposed that this material could be similarly used for duraplasty in human subjects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449077     DOI: 10.1097/00006123-199908000-00025

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  23 in total

1.  Intramural acellular porcine dermal matrix (APDM)-assisted gastrotomy closure for natural orifice transluminal endoscopic surgery (NOTES).

Authors:  Jegan Gopal; Eric M Pauli; Randy S Haluck; Matthew T Moyer; Abraham Mathew
Journal:  Surg Endosc       Date:  2012-02-23       Impact factor: 4.584

2.  Role of acellular dermal matrix allograft in minimal invasive coverage of deep burn wound with bone exposed--case report and histological evaluation.

Authors:  Krisztián Gáspár; Irén Erdei; Zoltán Péter; Balázs Dezsö; János Hunyadi; István Juhász
Journal:  Int Wound J       Date:  2006-03       Impact factor: 3.315

3.  Acellular dermal matrices: Use in reconstructive and aesthetic breast surgery.

Authors:  Sheina A Macadam; Peter A Lennox
Journal:  Can J Plast Surg       Date:  2012

Review 4.  Current opinions on indications and algorithms for acellular dermal matrix use in primary prosthetic breast reconstruction.

Authors:  Michael M Vu; John Y S Kim
Journal:  Gland Surg       Date:  2015-06

5.  Revascularization of AlloDerm Used during Endoscopic Skull Base Surgery.

Authors:  Zahrah M Taufique; Nupur Bhatt; David Zagzag; Richard A Lebowitz; Seth M Lieberman
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-06

6.  Activation of human mononuclear cells by porcine biologic meshes in vitro.

Authors:  S B Orenstein; Y Qiao; U Klueh; D L Kreutzer; Y W Novitsky
Journal:  Hernia       Date:  2010-02-10       Impact factor: 4.739

7.  Efficacy and safety of non-suture dural closure using a novel dural substitute consisting of polyglycolic acid felt and fibrin glue to prevent cerebrospinal fluid leakage-A non-controlled, open-label, multicenter clinical trial.

Authors:  Shunsuke Terasaka; Toshiaki Taoka; Satoshi Kuroda; Nobutaka Mikuni; Toru Nishi; Hiroyuki Nakase; Yukihiko Fujii; Yasuhiko Hayashi; Jun-Ichi Murata; Ken-Ichiro Kikuta; Toshihiko Kuroiwa; Sachie Shimokawa; Kiyohiro Houkin
Journal:  J Mater Sci Mater Med       Date:  2017-03-29       Impact factor: 3.896

8.  Does the use of an acellular dermal graft in abdominal closure after rectus flap harvest impact the occurrence of post-operative hernia?

Authors:  Masoud Saman; Sameep Kadakia; Yadranko Ducic
Journal:  Oral Maxillofac Surg       Date:  2015-04-26

9.  Ventral hernia repair using allogenic acellular dermal matrix in a swine model.

Authors:  R P Silverman; E N Li; L H Holton; K T Sawan; N H Goldberg
Journal:  Hernia       Date:  2004-12       Impact factor: 4.739

10.  Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study.

Authors:  Alexander Reyzelman; Ryan T Crews; John C Moore; Lily Moore; Jagpreet S Mukker; Stephen Offutt; Arthur Tallis; William B Turner; Dean Vayser; Christopher Winters; David G Armstrong
Journal:  Int Wound J       Date:  2009-04-02       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.